Literature DB >> 7236490

In vitro monocyte maturation in squamous carcinoma of the lung.

R G Dent, P Cole.   

Abstract

Maturation of monocytes into macrophages in vitro has been assayed by a quantitative microtitre assay in patients with squamous-cell carcinoma of the lung. Monocyte maturation in autologous serum was significantly depressed in patients with both limited and extensive disease compared with normal controls, patients with chronic obstructive airways disease and controls matched for age, sex, smoking history, respiratory function and the presence of infection. Maturation of monocytes from patients with terminal non-malignant disease was depressed, though not to the same extent as in those with extensive malignancy. Monocytes from relatives of patients with squamous-cell carcinoma of the lung matured normally. In 10 patients with limited disease, in vitro monocyte maturation was repeated 6-12 weeks after operation, and was found to relate to prognosis.

Entities:  

Mesh:

Year:  1981        PMID: 7236490      PMCID: PMC2010636          DOI: 10.1038/bjc.1981.71

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Cytolytic and cytostatic activity on tumor cells of circulating human monocytes.

Authors:  A Mantovani; T R Jerrells; J H Dean; R B Herberman
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

2.  The Formation of Macrophages, Epithelioid Cells and Giant Cells from Leucocytes in Incubated Blood.

Authors:  M R Lewis
Journal:  Am J Pathol       Date:  1925-01       Impact factor: 4.307

3.  Altered expression of human monocyte Fc receptors in malignant disease.

Authors:  J Rhodes
Journal:  Nature       Date:  1977-01-20       Impact factor: 49.962

4.  Serum-associated inhibition of leukotaxis in humans with cancer.

Authors:  E G Maderazo; T F Anton; P A Ward
Journal:  Clin Immunol Immunopathol       Date:  1978-02

5.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

6.  Reticulo-endothelial activity in humans with cancer.

Authors:  C J Magarey; M Baum
Journal:  Br J Surg       Date:  1970-10       Impact factor: 6.939

7.  Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion.

Authors:  D K Law; S J Dudrick; N I Abdou
Journal:  Ann Intern Med       Date:  1973-10       Impact factor: 25.391

8.  Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors.

Authors:  G A Currie; D W Hedley
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

9.  Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal.

Authors:  R Snyderman; H F Seigler; L Meadows
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

10.  Monocytes and macrophages in malignant melanoma IV. Effects of C. parvum on monocyte function.

Authors:  D W Hedley; R E Nyholm; G A Currie
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

View more
  8 in total

1.  Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer.

Authors:  M Carroll; K Lukacs; M Hodson; A B Kay
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

Review 2.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

3.  Receptor associated defects of cultured monocytes in bronchial carcinoma.

Authors:  K Lukacs; M P Carroll; M E Hodson; A B Kay
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  Ultrastructure of skin window cells in normal subjects.

Authors:  R J Sokol; J Wales; P D Norris; G Hudson
Journal:  J Anat       Date:  1982-10       Impact factor: 2.610

5.  Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A).

Authors:  J Rhodes; P Stokes; P Abrams
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study.

Authors:  Nina Turnsek; Rok Devjak; Natalija Edelbaher; Ilonka Osrajnik; Mojca Unk; Dusanka Vidovic; Tina Jeric; Urska Janzic
Journal:  Radiol Oncol       Date:  2022-08-14       Impact factor: 4.214

7.  In vitro monocyte maturation in squamous-cell carcinoma of the lung: influence of humoral factors.

Authors:  R G Dent; P J Cole
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

8.  Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.

Authors:  T Ikeda; T Masuno; T Ogura; M Watanabe; T Shirasaka; H Hara; Y Tanio; I Kawase; S Kishimoto
Journal:  Jpn J Cancer Res       Date:  1991-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.